๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
161 results for โ€œMerckโ€
MedicineActive substanceLicence holderStatus
HBVAXPRO
EU/1/01/183/007
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/008
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/009
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/010
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/011
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/012
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/013
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/014
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/015
Hepatitis b vaccine Merck Sharp & Dohme BV, Marketed
HBVAXPRO
EU/1/01/183/018-025
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO
EU/1/01/183/026-029
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
HBVAXPRO 5 micrograms, suspension for injection
EU/1/01/183/001
Hepatitis b vaccine Merck Sharp & Dohme BV, โ€”
Invanz
EU/1/02/216/001
Ertapenem sodium Merck Sharp & Dohme BV, โ€”
Isentress 100 mg Chewable tablet
EU/1/07/436/004
Raltegravir Merck Sharp & Dohme BV โ€”
Isentress 100 mg Granules for oral suspension
EU/1/07/436/005
Raltegravir Merck Sharp & Dohme BV โ€”
Isentress 25 mg Chewable tablet
EU/1/07/436/003
Raltegravir Merck Sharp & Dohme BV, โ€”
Isentress 400 mg Film-coated tablet
EU/1/07/436/1-2
Raltegravir potassium Merck Sharp & Dohme BV, โ€”
Isentress 600 mg Film-coated tablet
EU/1/07/436/006
Raltegravir Merck Sharp & Dohme BV โ€”
Ivemend 150 mg Powder for solution for infusion
EU/1/07/437/003-004
Fosaprepitant dimeglumine Merck Sharp & Dohme BV, โ€”
Janumet 50 mg/1000 mg film-coated tablets
EU/1/08/455/008-014
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV โ€”
Janumet 50 mg/850 mg film-coated tablets
EU/1/08/455/1-7
Sitagliptin phosphate, Metformin Hydrochloride Merck Sharp & Dohme BV, โ€”
Januvia 100 mg film-coated tablets
EU/1/07/383/13-18
Sitagliptin phosphate monohydrate Merck Sharp & Dohme BV โ€”
Januvia 25 mg film-coated tablets
EU/1/07/383/1-6
Sitagliptin phosphate monohydrate Merck Sharp & Dohme BV, โ€”
Januvia 50 mg film-coated tablets
EU/1/07/383/7-12
Sitagliptin phosphate monohydrate Merck Sharp & Dohme BV โ€”
KEYTRUDA 25 mg/mL concentrate for solution for infusion
EU/1/15/1024/002
Pembrolizumab Merck Sharp & Dohme BV, โ€”
Luveris
EU/1/00/155/001
Lutropin alfa Merck Europe B.V. โ€”
Luveris
EU/1/00/155/002
Lutropin alfa Merck Europe B.V. โ€”
Luveris
EU/1/00/155/003
Lutropin alfa Merck Europe B.V. โ€”
Luveris
EU/1/00/155/007
Lutropin alfa Merck Europe B.V. โ€”
Luveris 75 IU powder and solvent for solution for injection
EU/1/00/155/004
Lutropin alfa Merck Europe B.V. โ€”
Luveris 75 IU powder and solvent for solution for injection
EU/1/00/155/005
Lutropin alfa Merck Europe B.V. โ€”
Luveris 75 IU powder and solvent for solution for injection
EU/1/00/155/006
Lutropin alfa Merck Europe B.V. โ€”
LYFNUA 45 mg Film-coated tablet
EU/1/21/1613/001-004
Gefapixant Merck Sharp & Dohme BV, โ€”
M-M-RvaxPro powder and solvent for suspension for injection Measles, mumps and rubella vaccine (live)
EU/1/06/337/1-13
Mumps virus live attenuated jeryl lynn strain, Rubella virus (wistar ra 27/3 strain) live attenuated, Measles virus live attenuated derived from the edmonston b strain Merck Sharp & Dohme BV, โ€”
MAVENCLAD 10 mg tablets
EU/1/17/1212/001-006
Cladribine Merck Europe B.V. โ€”
Noxafil 100 mg gastro-resistant tablets
EU/1/05/320/002-003
Posaconazole Merck Sharp & Dohme BV, โ€”
Noxafil 300 mg concentrate for solution for infusion
EU/1/05/320/004
Posaconazole Merck Sharp & Dohme BV, โ€”
Noxafil 300 mg gastro-resistant powder for oral suspension
EU/1/05/320/005
Posaconazole Merck Sharp & Dohme BV, โ€”
Noxafil 40 mg/ml oral suspension
EU/1/05/320/001
Posaconazole Merck Sharp & Dohme BV, โ€”
Ovitrelle 250 micrograms solution for injection in pre-filled pen
EU/1/00/165/008
Choriogonadotropin alfa Merck Europe B.V. โ€”
Pergoveris (300 IU + 150 IU)/0.48 mL solution for injection in pre-filled pen
EU/1/07/396/004
Lutropin alfa, Follitropin alfa Merck Europe B.V. โ€”
Pergoveris (450 IU + 225 IU)/0.72 mL solution for injection in pre-filled pen
EU/1/07/396/005
Lutropin alfa, Follitropin alfa Merck Europe B.V. โ€”
Pergoveris (900 IU + 450 IU)/1.44 mL solution for injection in pre-filled pen
EU/1/07/396/006
Lutropin alfa, Follitropin alfa Merck Europe B.V. โ€”
Pergoveris 150 IU/75 IU powder and solvent for solution for injection
EU/1/07/396/1-3
Lutropin alfa, Follitropin alfa Merck Europe B.V. โ€”
Pifeltro 100 mg film-coated tablets
EU/1/18/1332/001-002
Doravirine Merck Sharp & Dohme BV, โ€”
PNEUMOVAX 23 solution for injection in a vial Pneumococcal Polysaccharide Vaccine
PA1286/055/001
Pneumococcal vaccine Merck Sharp & Dohme Ireland (Human Health) Limited Not marketed
PNEUMOVAX 23 solution for injection in pre-filled syringe Pneumococcal Polysaccharide Vaccine
PA1286/055/002
Pneumococcal vaccine Merck Sharp & Dohme Ireland (Human Health) Limited Marketed
PREVYMIS 240 mg Concentrate for solution for infusion
EU/1/17/1245/003
LETERMOVIR Merck Sharp & Dohme BV โ€”
PREVYMIS 240 mg Film-coated tablet
EU/1/17/1245/001
LETERMOVIR Merck Sharp & Dohme BV, โ€”
PREVYMIS 480 mg Concentrate for solution for infusion
EU/1/17/1245/004
LETERMOVIR Merck Sharp & Dohme BV โ€”
โ† 1 2 3 4 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.